<?xml version="1.0" encoding="UTF-8"?>
<!-- このサイトマップは、2026年6月23日の7:34 AMに、WordPress 用のオリジナル SEO プラグイン All in One SEO v4.6.5により動的生成されました。 -->

<?xml-stylesheet type="text/xsl" href="https://czeek.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>CzeekV インデックス</title>
		<link><![CDATA[https://czeek.com]]></link>
		<description><![CDATA[CzeekV インデックス]]></description>
		<lastBuildDate><![CDATA[Mon, 22 Jun 2026 07:15:28 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://czeek.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://czeek.com/ronbun/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/]]></link>
			<title>論文・技術情報</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 07:15:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/information-884/]]></guid>
			<link><![CDATA[https://czeek.com/information-884/]]></link>
			<title>論文・技術情報追加のお知らせ</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 07:15:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/the-provision-of-cognitive-behavioral-therapy-in-japan-an-analysis-using-insurance-claims-data/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/the-provision-of-cognitive-behavioral-therapy-in-japan-an-analysis-using-insurance-claims-data/]]></link>
			<title>The provision of cognitive behavioral therapy in Japan: an analysis using insurance claims data.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:54:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/current-hypertension-epidemiology-and-contemporary-approaches-using-the-real-world-evidence-cycle-framework/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/current-hypertension-epidemiology-and-contemporary-approaches-using-the-real-world-evidence-cycle-framework/]]></link>
			<title>Current hypertension epidemiology and contemporary approaches using the &#8220;Real-World Evidence Cycle&#8221; framework.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:54:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/multiple-or-single-endocrine-abnormalities-associated-with-immune-checkpoint-inhibitors/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/multiple-or-single-endocrine-abnormalities-associated-with-immune-checkpoint-inhibitors/]]></link>
			<title>Multiple or Single Endocrine Abnormalities Associated With Immune Checkpoint Inhibitors.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:54:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/impact-of-impaired-fasting-or-diabetes-compared-with-that-of-smoking-habit-on-tooth-loss/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/impact-of-impaired-fasting-or-diabetes-compared-with-that-of-smoking-habit-on-tooth-loss/]]></link>
			<title>Impact of Impaired Fasting or Diabetes Compared with That of Smoking Habit on Tooth Loss.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:54:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/family-pharmacist-system-for-patients-with-chronic-cardiovascular-or-endocrine-disease/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/family-pharmacist-system-for-patients-with-chronic-cardiovascular-or-endocrine-disease/]]></link>
			<title>Family Pharmacist System for Patients With Chronic Cardiovascular or Endocrine Disease.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:54:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/effects-of-sglt2-inhibitors-on-nsaid-associated-acute-kidney-injury-in-type-2-diabetes-a-claims-based-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/effects-of-sglt2-inhibitors-on-nsaid-associated-acute-kidney-injury-in-type-2-diabetes-a-claims-based-cohort-study/]]></link>
			<title>Effects of SGLT2 inhibitors on NSAID-associated acute kidney injury in type 2 diabetes: a claims-based cohort study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:54:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/long-term-outcomes-associated-with-istradefylline-versus-catechol-o-methyltransferase-inhibitors-in-patients-with-parkinsons-disease-a-nationwide-real-world-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/long-term-outcomes-associated-with-istradefylline-versus-catechol-o-methyltransferase-inhibitors-in-patients-with-parkinsons-disease-a-nationwide-real-world-cohort-study/]]></link>
			<title>Long-term outcomes associated with istradefylline versus catechol-O-methyltransferase inhibitors in patients with Parkinson&#8217;s disease: a nationwide real-world cohort study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:54:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/appropriate-definition-of-childbirth-using-japanese-administrative-database-a-cross-sectional-cohort-validation-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/appropriate-definition-of-childbirth-using-japanese-administrative-database-a-cross-sectional-cohort-validation-study/]]></link>
			<title>Appropriate definition of childbirth using Japanese administrative database: a cross-sectional cohort validation study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:54:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/cardiac-monitoring-in-adolescent-and-young-adult-cancer-patients-treated-with-anthracyclines-a-longitudinal-descriptive-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/cardiac-monitoring-in-adolescent-and-young-adult-cancer-patients-treated-with-anthracyclines-a-longitudinal-descriptive-study/]]></link>
			<title>Cardiac monitoring in adolescent and young adult cancer patients treated with anthracyclines: a longitudinal descriptive study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:54:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/early-adoption-of-lecanemab-in-japan-december-2023-december-2024-pretreatment-diagnostic-timelines-from-the-desc-claims-database/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/early-adoption-of-lecanemab-in-japan-december-2023-december-2024-pretreatment-diagnostic-timelines-from-the-desc-claims-database/]]></link>
			<title>Early adoption of lecanemab in Japan (December 2023-December 2024): Pretreatment diagnostic timelines from the DeSC claims database.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:54:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/adherence-and-persistence-among-individuals-living-with-type-2-diabetes-and-using-a-free-combination-of-basal-insulin-and-an-injectable-glucagon-like-peptide-1-receptor-agonist-versus-a-fixed-ratio-co/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/adherence-and-persistence-among-individuals-living-with-type-2-diabetes-and-using-a-free-combination-of-basal-insulin-and-an-injectable-glucagon-like-peptide-1-receptor-agonist-versus-a-fixed-ratio-co/]]></link>
			<title>Adherence and Persistence Among Individuals Living With Type 2 Diabetes and Using a Free Combination of Basal Insulin and an Injectable Glucagon-Like Peptide-1 Receptor Agonist Versus a Fixed-Ratio Combination Therapy: A Japanese Database Study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:54:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/impacts-of-cost-sharing-rate-increment-on-the-expenditure-of-outpatient-care-among-older-adults-quasi-experimental-study-of-cost-sharing-reform-in-japan/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/impacts-of-cost-sharing-rate-increment-on-the-expenditure-of-outpatient-care-among-older-adults-quasi-experimental-study-of-cost-sharing-reform-in-japan/]]></link>
			<title>Impacts of cost-sharing rate increment on the expenditure of outpatient care among older adults: quasi-experimental study of cost-sharing reform in Japan.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:54:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/population-attributable-fraction-of-modifiable-risk-factors-for-incident-hypertension-an-analysis-of-large-scale-epidemiological-cohort/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/population-attributable-fraction-of-modifiable-risk-factors-for-incident-hypertension-an-analysis-of-large-scale-epidemiological-cohort/]]></link>
			<title>Population attributable fraction of modifiable risk factors for incident hypertension: an analysis of large-scale epidemiological cohort.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/effects-of-smartphone-cognitive-behavioural-therapy-on-social-functioning-in-non-depressive-and-subthreshold-depressive-adults-a-secondary-analysis-of-the-resilient-trial/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/effects-of-smartphone-cognitive-behavioural-therapy-on-social-functioning-in-non-depressive-and-subthreshold-depressive-adults-a-secondary-analysis-of-the-resilient-trial/]]></link>
			<title>Effects of smartphone cognitive behavioural therapy on social functioning in non-depressive and subthreshold depressive adults: a secondary analysis of the RESiLIENT trial.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/incidence-of-skin-infections-in-patients-with-atopic-dermatitis-treated-with-topical-medications-a-cohort-study-using-japanese-claims-data/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/incidence-of-skin-infections-in-patients-with-atopic-dermatitis-treated-with-topical-medications-a-cohort-study-using-japanese-claims-data/]]></link>
			<title>Incidence of Skin Infections in Patients with Atopic Dermatitis Treated with Topical Medications: A Cohort Study Using Japanese Claims Data.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/association-of-weight-loss-with-improvement-in-metabolic-status-among-people-eligible-for-the-specific-health-guidance-program/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/association-of-weight-loss-with-improvement-in-metabolic-status-among-people-eligible-for-the-specific-health-guidance-program/]]></link>
			<title>Association of Weight Loss With Improvement in Metabolic Status Among People Eligible for the Specific Health Guidance Program.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/trends-in-anti-osteoporosis-pharmacotherapy-and-pharmacological-initiation-for-secondary-fracture-prevention-in-japan-2017-2023/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/trends-in-anti-osteoporosis-pharmacotherapy-and-pharmacological-initiation-for-secondary-fracture-prevention-in-japan-2017-2023/]]></link>
			<title>Trends in anti-osteoporosis pharmacotherapy and pharmacological initiation for secondary fracture prevention in Japan, 2017-2023.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/anemia-visits-and-clinical-patterns-after-identification-of-low-hemoglobin-at-health-checkups-among-women-of-reproductive-age-in-japan-a-real-world-claims-and-health-checkup-data-study-award-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/anemia-visits-and-clinical-patterns-after-identification-of-low-hemoglobin-at-health-checkups-among-women-of-reproductive-age-in-japan-a-real-world-claims-and-health-checkup-data-study-award-study/]]></link>
			<title>Anemia visits and clinical patterns after identification of low hemoglobin at health checkups among women of reproductive age in Japan: a real-world claims and health checkup data study (AWARD study).</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/long-term-outcomes-after-ischemic-stroke-across-atrial-fibrillation-phenotypes-defined-by-detection-timing-and-prior-anticoagulation-status/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/long-term-outcomes-after-ischemic-stroke-across-atrial-fibrillation-phenotypes-defined-by-detection-timing-and-prior-anticoagulation-status/]]></link>
			<title>Long-Term Outcomes After Ischemic Stroke Across Atrial Fibrillation Phenotypes Defined by Detection Timing and Prior Anticoagulation Status.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/application-of-a-language-model-tool-for-covid-19-vaccine-adverse-event-monitoring-using-web-and-social-media-content-algorithm-development-and-validation-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/application-of-a-language-model-tool-for-covid-19-vaccine-adverse-event-monitoring-using-web-and-social-media-content-algorithm-development-and-validation-study/]]></link>
			<title>Application of a Language Model Tool for COVID-19 Vaccine Adverse Event Monitoring Using Web and Social Media Content: Algorithm Development and Validation Study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/hypersensitivity-to-intravenous-lipid-emulsions-and-food-allergies-a-systematic-review-of-case-reports/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/hypersensitivity-to-intravenous-lipid-emulsions-and-food-allergies-a-systematic-review-of-case-reports/]]></link>
			<title>Hypersensitivity to Intravenous Lipid Emulsions and Food Allergies: a Systematic Review of Case Reports.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/durvalumab-after-chemoradiotherapy-for-locally-advanced-nsclc-a-real-world-analysis-using-a-nationwide-claims-database-in-japan/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/durvalumab-after-chemoradiotherapy-for-locally-advanced-nsclc-a-real-world-analysis-using-a-nationwide-claims-database-in-japan/]]></link>
			<title>Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC: A Real-World Analysis Using a Nationwide Claims Database in Japan.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/oral-adverse-event-reporting-in-smoking-cessation-trials-using-non-combustible-nicotine-products-a-quality-assessment/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/oral-adverse-event-reporting-in-smoking-cessation-trials-using-non-combustible-nicotine-products-a-quality-assessment/]]></link>
			<title>Oral adverse event reporting in smoking cessation trials using non-combustible nicotine products: A quality assessment.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/atorvastatin-associated-liver-injury-outcome-after-statin-rechallenge/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/atorvastatin-associated-liver-injury-outcome-after-statin-rechallenge/]]></link>
			<title>Atorvastatin-Associated Liver Injury: Outcome After Statin Rechallenge.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/time-and-patient-journey-to-axial-spondyloarthritis-diagnosis-a-retrospective-study-in-french-primary-care/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/time-and-patient-journey-to-axial-spondyloarthritis-diagnosis-a-retrospective-study-in-french-primary-care/]]></link>
			<title>Time and patient journey to axial spondyloarthritis diagnosis: a retrospective study in French primary care.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/botulinum-toxin-type-a-for-subacute-chronic-neck-pain/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/botulinum-toxin-type-a-for-subacute-chronic-neck-pain/]]></link>
			<title>Botulinum toxin type A for subacute/chronic neck pain.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/a-preliminary-study-on-the-efficacy-and-safety-of-a-novel-digital-therapeutic-device-a-randomized-clinical-trial-in-south-korean-pediatric-patients-with-attention-deficit-hyperactivity-disorder/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/a-preliminary-study-on-the-efficacy-and-safety-of-a-novel-digital-therapeutic-device-a-randomized-clinical-trial-in-south-korean-pediatric-patients-with-attention-deficit-hyperactivity-disorder/]]></link>
			<title>A Preliminary Study on the Efficacy and Safety of a Novel Digital Therapeutic Device: A Randomized Clinical Trial in South Korean Pediatric Patients With Attention-Deficit/Hyperactivity Disorder.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/assessing-the-cardiovascular-effects-of-levothyroxine-use-in-an-ageing-uk-population-with-subclinical-hypothyroidism-emulated-target-trial-acel-uk-ett/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/assessing-the-cardiovascular-effects-of-levothyroxine-use-in-an-ageing-uk-population-with-subclinical-hypothyroidism-emulated-target-trial-acel-uk-ett/]]></link>
			<title>Assessing the Cardiovascular Effects of Levothyroxine Use in an Ageing UK Population with Subclinical Hypothyroidism: Emulated Target Trial (ACEL-UK-ETT).</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/sodium-glucose-cotransporter-2-inhibitors-and-the-risk-of-atrial-fibrillation-in-patients-with-type-2-diabetes-a-population-based-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/sodium-glucose-cotransporter-2-inhibitors-and-the-risk-of-atrial-fibrillation-in-patients-with-type-2-diabetes-a-population-based-cohort-study/]]></link>
			<title>Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/fluoroquinolones-and-the-risk-of-severe-hypoglycaemia-among-sulphonylurea-users-population-based-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/fluoroquinolones-and-the-risk-of-severe-hypoglycaemia-among-sulphonylurea-users-population-based-cohort-study/]]></link>
			<title>Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/incretin-based-therapy-and-the-risk-of-diabetic-foot-ulcers-and-related-events/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/incretin-based-therapy-and-the-risk-of-diabetic-foot-ulcers-and-related-events/]]></link>
			<title>Incretin-based therapy and the risk of diabetic foot ulcers and related events.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/glucosamine-and-cancer-incidence-in-osteoarthritis-a-prevalent-new-user-cohort-design/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/glucosamine-and-cancer-incidence-in-osteoarthritis-a-prevalent-new-user-cohort-design/]]></link>
			<title>Glucosamine and Cancer Incidence in Osteoarthritis: A Prevalent New-User Cohort Design.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/oral-anticoagulants-and-the-risk-of-dementia-in-patients-with-nonvalvular-atrial-fibrillation-a-population-based-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/oral-anticoagulants-and-the-risk-of-dementia-in-patients-with-nonvalvular-atrial-fibrillation-a-population-based-cohort-study/]]></link>
			<title>Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/psoriasis-and-dementia-a-population-based-matched-cohort-study-of-adults-in-england/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/psoriasis-and-dementia-a-population-based-matched-cohort-study-of-adults-in-england/]]></link>
			<title>Psoriasis and dementia: A population-based matched cohort study of adults in England.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/is-alcohol-use-disorder-associated-with-higher-rates-of-depression-and-anxiety-among-people-with-new-onset-type-2-diabetes-a-cohort-study-using-linked-primary-care-data-in-england/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/is-alcohol-use-disorder-associated-with-higher-rates-of-depression-and-anxiety-among-people-with-new-onset-type-2-diabetes-a-cohort-study-using-linked-primary-care-data-in-england/]]></link>
			<title>Is alcohol use disorder associated with higher rates of depression and anxiety among people with new onset type 2 diabetes? A cohort study using linked primary care data in England.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/incidence-of-side-effects-associated-with-acetaminophen-in-people-aged-65-years-or-more-a-prospective-cohort-study-using-data-from-the-clinical-practice-research-datalink/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/incidence-of-side-effects-associated-with-acetaminophen-in-people-aged-65-years-or-more-a-prospective-cohort-study-using-data-from-the-clinical-practice-research-datalink/]]></link>
			<title>Incidence of Side Effects Associated With Acetaminophen in People Aged 65 Years or More: A Prospective Cohort Study Using Data From the Clinical Practice Research Datalink.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/comparison-of-oral-anticoagulants-for-stroke-prevention-in-atrial-fibrillation-using-the-uk-clinical-practice-research-datalink-aurum-a-reference-trial-aristotle-emulation-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/comparison-of-oral-anticoagulants-for-stroke-prevention-in-atrial-fibrillation-using-the-uk-clinical-practice-research-datalink-aurum-a-reference-trial-aristotle-emulation-study/]]></link>
			<title>Comparison of oral anticoagulants for stroke prevention in atrial fibrillation using the UK clinical practice research Datalink Aurum: A reference trial (ARISTOTLE) emulation study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/risk-of-severe-exacerbation-associated-with-gabapentinoid-use-in-patients-with-chronic-obstructive-pulmonary-disease-a-population-based-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/risk-of-severe-exacerbation-associated-with-gabapentinoid-use-in-patients-with-chronic-obstructive-pulmonary-disease-a-population-based-cohort-study/]]></link>
			<title>Risk of Severe Exacerbation Associated with Gabapentinoid Use in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/levothyroxine-treatment-for-subclinical-hypothyroidism-and-risk-of-adverse-renal-outcomes-a-population-based-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/levothyroxine-treatment-for-subclinical-hypothyroidism-and-risk-of-adverse-renal-outcomes-a-population-based-cohort-study/]]></link>
			<title>Levothyroxine treatment for subclinical hypothyroidism and risk of adverse renal outcomes: a population-based cohort study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/deprescribing-of-preventive-medications-in-palliative-care-patients-living-with-multiple-long-term-conditions-in-their-final-12-months-of-life-a-retrospective-cohort-clinical-practice-research-datali/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/deprescribing-of-preventive-medications-in-palliative-care-patients-living-with-multiple-long-term-conditions-in-their-final-12-months-of-life-a-retrospective-cohort-clinical-practice-research-datali/]]></link>
			<title>Deprescribing of preventive medications in palliative care patients living with multiple long-term conditions in their final 12 months of life: A retrospective cohort Clinical Practice Research Datalink study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/mortality-and-hospital-admissions-in-people-with-eating-disorders-longitudinal-cohort-study-in-secondary-care-linked-english-primary-care-records/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/mortality-and-hospital-admissions-in-people-with-eating-disorders-longitudinal-cohort-study-in-secondary-care-linked-english-primary-care-records/]]></link>
			<title>Mortality and hospital admissions in people with eating disorders: longitudinal cohort study in secondary care-linked English primary care records.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/the-effect-of-use-of-tricyclic-antidepressants-or-serotonin-norepinephrine-reuptake-inhibitors-versus-selective-serotonin-reuptake-inhibitors-on-the-risk-of-urinary-tract-infection-among-people-with-m/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/the-effect-of-use-of-tricyclic-antidepressants-or-serotonin-norepinephrine-reuptake-inhibitors-versus-selective-serotonin-reuptake-inhibitors-on-the-risk-of-urinary-tract-infection-among-people-with-m/]]></link>
			<title>The Effect of Use of Tricyclic Antidepressants or Serotonin-Norepinephrine Reuptake Inhibitors Versus Selective Serotonin Reuptake Inhibitors on the Risk of Urinary Tract Infection Among People With Multiple Sclerosis: A Nested Case-Control Study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/time-to-diagnosis-and-long-term-outcomes-for-adults-presenting-with-breathlessness/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/time-to-diagnosis-and-long-term-outcomes-for-adults-presenting-with-breathlessness/]]></link>
			<title>Time to diagnosis and long-term outcomes for adults presenting with breathlessness.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/effectiveness-and-safety-of-rivaroxaban-vs-apixaban-in-patients-with-atrial-fibrillation-and-peripheral-artery-disease/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/effectiveness-and-safety-of-rivaroxaban-vs-apixaban-in-patients-with-atrial-fibrillation-and-peripheral-artery-disease/]]></link>
			<title>Effectiveness and safety of rivaroxaban vs. apixaban in patients with atrial fibrillation and peripheral artery disease.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/pre-diagnostic-features-of-multiple-sclerosis-in-a-diverse-uk-cohort-a-nested-case-control-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/pre-diagnostic-features-of-multiple-sclerosis-in-a-diverse-uk-cohort-a-nested-case-control-study/]]></link>
			<title>Pre-Diagnostic Features of Multiple Sclerosis in a Diverse UK Cohort: A Nested Case-Control Study.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/comparing-ipcw-models-to-adjust-for-informative-censoring-during-covid-19-using-data-from-the-clinical-practice-research-datalink/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/comparing-ipcw-models-to-adjust-for-informative-censoring-during-covid-19-using-data-from-the-clinical-practice-research-datalink/]]></link>
			<title>Comparing IPCW Models to Adjust for Informative Censoring During COVID-19 Using Data From the Clinical Practice Research Datalink.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/co-prescribing-of-antidepressants-and-opioids-for-non-cancer-pain-in-england-2010-2019-a-descriptive-study-using-cprd-primary-care-electronic-health-records/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/co-prescribing-of-antidepressants-and-opioids-for-non-cancer-pain-in-england-2010-2019-a-descriptive-study-using-cprd-primary-care-electronic-health-records/]]></link>
			<title>Co-prescribing of antidepressants and opioids for non-cancer pain in England, 2010-2019: a descriptive study using CPRD primary care electronic health records.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/assessment-of-a-modified-high-dimensional-propensity-score-approach-for-uk-electronic-health-record-data-evaluating-upper-gastrointestinal-safety-of-nsaids-and-cox-2-inhibitors/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/assessment-of-a-modified-high-dimensional-propensity-score-approach-for-uk-electronic-health-record-data-evaluating-upper-gastrointestinal-safety-of-nsaids-and-cox-2-inhibitors/]]></link>
			<title>Assessment of a Modified High-Dimensional Propensity Score Approach for UK Electronic Health Record Data: Evaluating Upper Gastrointestinal Safety of NSAIDs and COX-2 Inhibitors.</title>
			<pubDate><![CDATA[Mon, 22 Jun 2026 06:53:47 +0000]]></pubDate>
		</item>
				</channel>
</rss>
